Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Other financing activities: 2021-2024

Historic Other financing activities for Taysha Gene Therapies (TSHA) over the last 4 years, with Dec 2024 value amounting to -$167,000.

  • Taysha Gene Therapies' Other financing activities fell 70.66% to -$285,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$204,000, marking a year-over-year decrease of 146.15%. This contributed to the annual value of -$167,000 for FY2024, which is 141.85% down from last year.
  • According to the latest figures from FY2024, Taysha Gene Therapies' Other financing activities is -$167,000, which was down 141.85% from $399,000 recorded in FY2023.
  • Taysha Gene Therapies' 5-year Other financing activities high stood at $399,000 for FY2023, and its period low was -$1.0 million during FY2022.
  • For the 3-year period, Taysha Gene Therapies' Other financing activities averaged around -$270,000, with its median value being -$167,000 (2024).
  • Per our database at Business Quant, Taysha Gene Therapies' Other financing activities soared by 138.29% in 2023 and then slumped by 141.85% in 2024.
  • Yearly analysis of 4 years shows Taysha Gene Therapies' Other financing activities stood at -$514,000 in 2021, then slumped by 102.72% to -$1.0 million in 2022, then soared by 138.29% to $399,000 in 2023, then crashed by 141.85% to -$167,000 in 2024.